Cibus, Inc. Reports Exit and Disposal Costs
Ticker: CBUS · Form: 8-K · Filed: Oct 18, 2024 · CIK: 1705843
| Field | Detail |
|---|---|
| Company | Cibus, Inc. (CBUS) |
| Form Type | 8-K |
| Filed Date | Oct 18, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $0.35 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: restructuring, disposal, corporate-actions
TL;DR
Cibus is shedding assets/operations, expect costs.
AI Summary
Cibus, Inc. reported on October 16, 2024, that it is incurring costs associated with exit or disposal activities. The company, formerly known as Calyxt, Inc., is based in San Diego, California, and operates in the agriculture chemicals sector.
Why It Matters
This filing indicates that Cibus, Inc. is undergoing restructuring or divesting certain operations, which could impact its future financial performance and strategic direction.
Risk Assessment
Risk Level: medium — Disposal activities can signal financial distress or strategic shifts that carry inherent risks for investors.
Key Players & Entities
- Cibus, Inc. (company) — Registrant
- Calyxt, Inc. (company) — Former company name
- October 16, 2024 (date) — Date of earliest event reported
- San Diego, CA (location) — Principal executive offices
- Delaware (location) — State of incorporation
FAQ
What specific activities are associated with the exit or disposal?
The filing states that the company is incurring costs associated with exit or disposal activities, but does not specify the exact nature of these activities.
When did these exit or disposal activities begin?
The earliest event reported in relation to these activities is October 16, 2024.
What is the former name of Cibus, Inc.?
The former name of Cibus, Inc. was Calyxt, Inc.
Where are Cibus, Inc.'s principal executive offices located?
Cibus, Inc.'s principal executive offices are located at 6455 Nancy Ridge Drive, San Diego, CA 92121.
What is the SIC code for Cibus, Inc.?
The Standard Industrial Classification (SIC) code for Cibus, Inc. is 2870, which falls under AGRICULTURE CHEMICALS.
Filing Stats: 1,111 words · 4 min read · ~4 pages · Grade level 17.7 · Accepted 2024-10-18 16:23:52
Key Financial Figures
- $0.0001 — which registered Class A Common Stock, $0.0001 par value per share CBUS The Nasdaq
- $0.35 million — imates that it will incur approximately $0.35 million of one-time costs in the fourth quarter
Filing Documents
- d862315d8k.htm (8-K) — 26KB
- 0001193125-24-239649.txt ( ) — 143KB
- cbus-20241016.xsd (EX-101.SCH) — 3KB
- cbus-20241016_lab.xml (EX-101.LAB) — 17KB
- cbus-20241016_pre.xml (EX-101.PRE) — 11KB
- d862315d8k_htm.xml (XML) — 3KB
Forward-Looking Statements
Forward-Looking Statements This 8-K contains "forward-looking statements" within the meaning of applicable securities laws, including The Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included herein, including statements regarding Cibus' cost reduction initiatives, reduction in headcount and associated costs, as well as Cibus' strategy, future operations, prospects, and plans are forward-looking statements. Forward-looking statements may be identified by words such as "anticipate," "believe," "intend," "expect," "plan," "scheduled," "could," "would" and "will," or the negative of these and similar expressions. These forward-looking statements are based on the current expectations and assumptions of Cibus' management about future events, which are based on currently available information. These forward-looking statements are subject to numerous risks and uncertainties, many of which are difficult to predict and beyond the control of Cibus. Cibus' actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to: Cibus' need for additional near-term funding to finance its activities and challenges in obtaining additional capital on acceptable terms, or at all; changes in expected or existing competition; challenges to Cibus' intellectual property protection and unexpected costs associated with defending intellectual property rights; increased or unanticipated time and resources required for Cibus' platform or trait product development efforts; Cibus' reliance on third parties in connection with its development activities; challenges associated with Cibus' ability to effectively license its productivity traits and sustainable ingredient products; the risk that farmers do not recognize the value in germplasm containing Cibus' traits o
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Cibus, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 18, 2024 CIBUS, INC. By: /s/ Rory Riggs Name: Rory Riggs Title: Chief Executive Officer and Chairman